Overall Survival Up With Surgical Treatment in T3 Glottic SCC

This article originally appeared here.
Share this content:
Overall Survival Up With Surgical Treatment in T3 Glottic SCC
Overall Survival Up With Surgical Treatment in T3 Glottic SCC

MONDAY, July 11, 2016 (HealthDay News) -- Patients with T3 glottic squamous cell carcinoma (SCC) have improved overall survival (OS) with surgical treatment versus nonsurgical management, according to a study published online July 7 in JAMA Otolaryngology-Head & Neck Surgery.

Maha Al-Gilani, M.B.B.S., from the Washington University School of Medicine in St. Louis, and colleagues compared OS and functional outcomes in a secondary analysis using data from patients with T3 glottic SCC receiving nonsurgical and surgical management.

The researchers found that the five-year OS was 36, 41, and 41 percent, respectively, for nonsurgical management, surgery alone, and surgery plus adjuvant treatment. In multivariable analyses, the adjusted hazard ratios for OS were 0.68 and 0.75 for patients receiving surgery alone versus nonsurgical management and for patients receiving surgery plus adjuvant treatment versus nonsurgical management, respectively. Patients receiving surgery plus nonadjuvant treatment had the highest gastrostomy tube dependence (30.6 percent). Patients receiving chemoradiotherapy had the highest tracheostomy dependence (37 percent).

"Overall survival showed a statistically significant and clinically meaningful improvement in patients with T3 glottic SCC who underwent surgery compared with a nonsurgical treatment," the authors write. "Furthermore, the data suggest that adjuvant and nonsurgical treatment result in a dysfunctional larynx; however, this association needs further study."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

SABCS: Artificial Intelligence May Aid Doctors in Breast Cancer Care

SABCS: Artificial Intelligence May Aid Doctors in Breast ...

'Watson Oncology' agreed with doctors 90 percent of the time in many cases, researchers find

SABCS: Scalp-Cooling System Can Reduce Chemo-Related Hair Loss

SABCS: Scalp-Cooling System Can Reduce Chemo-Related Hair Loss

Devices reduce blood flow to hair follicles during chemotherapy treatments

SABCS: Aromatase Inhibitors Tied to Reduced Endothelial Function

SABCS: Aromatase Inhibitors Tied to Reduced Endothelial Function

Women on aromatase inhibitors exhibit less elasticity in their blood vessels

is free, fast, and customized just for you!

Already a member?

Sign In Now »